The Application of Contrast-enhanced Ultrasound in Acute Kidney Injury in ICU
1 other identifier
observational
44
1 country
1
Brief Summary
The goal of this study is to quantitatively assess renal microcirculation changes by contrast-enhanced ultrasound and to obtain systemic hemodynamic information by ultrasound Doppler at the same time, to analyze the relationship between renal microcirculation changes and systemic hemodynamic changes, and to explore its predictive value in renal function recovery in patients with critical acute kidney injury. The main questions it aims to answer are:
- 1.To explore the quantitative parameters of contrast-enhanced ultrasound which can reflect the changes of renal microcirculation.
- 2.To explore the relationship between renal microcirculation and systemic hemodynamics.
- 3.To explore the value of renal microflow changes quantitatively evaluated by contrast-enhanced ultrasound in predicting renal function recovery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 17, 2024
CompletedFirst Posted
Study publicly available on registry
April 2, 2024
CompletedStudy Start
First participant enrolled
April 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
ExpectedFebruary 17, 2025
February 1, 2025
1.2 years
March 17, 2024
February 13, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Serum creatinine values and/or urine output
Complete recovery (defined as a return to normal serum creatinine and urine volume) and reversal of acute kidney injury (AKI) (more than 50% improvement in serum creatinine and/or urine volume from baseline), non-recovery included persistent AKI(no significant improvement or further increase in serum creatinine and/or urine volume, the need for dialysis, or death.)
Through study completion, an average of 7 days
Study Arms (2)
Patients recovering before hospital discharge
Recovery is defined as a return to normal serum creatinine and urine volume or more than 50% improvement in serum creatinine and/or urine volume from baseline
Patients not recovering before hospital discharge
Non-recovery is defined as no significant improvement or further increase in serum creatinine and/or urine volume, the need for dialysis, or death.
Interventions
Renal microcirculation quantitatively assessed by Contrast-enhanced ultrasound before hospital discharge
Eligibility Criteria
Published contrast-enhanced ultrasound data from critically ill patients are limited. Through literature review, the area under the curve of contrast-enhanced ultrasound to predict kidney recovery in critically ill AKI patients is 0.72, and the width of confidence interval is 0.35. When α=0.05, the sample size N=34 is obtained by using PASS software. Considering the 20% shedding rate, 44 patients are expected to be enrolled in this study.
You may qualify if:
- Age \>18 years old;
- AKI was diagnosed \< 24 hours after first admission to intensive care unit (ICU) and the expected length of stay in ICU ≥48 hours;
- Meet Kidney Disease Improving Global Outcomes (KDIGO) 2012 diagnostic criteria for acute kidney injury;
- Contrast-enhanced ultrasound was performed within 24 hours after diagnosis of acute kidney injury (AKI).
You may not qualify if:
- Known severe chronic kidney disease (CKD≥ stage 4) or undergoing hemodialysis treatment;
- Kidney transplantation or renal malignancy;
- Terminal stage of malignant tumor;
- Pregnancy;
- Renal artery stenosis or renal vein thrombosis;
- Allergy to contrast agent SonoVue(BraccoSpA, Milan, Italy) or its components, or the presence of severe cardiopulmonary insufficiency (e.g., right-to-left shunt heart disease or pulmonary systolic blood pressure \>90mmHg).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Ultrasound Diagnosis, Peking University Third Hospital
Beijing, Beijing Municipality, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ligang Cui, Dr
Department of Ultrasound, Peking University Third Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief Physician
Study Record Dates
First Submitted
March 17, 2024
First Posted
April 2, 2024
Study Start
April 15, 2024
Primary Completion
June 30, 2025
Study Completion (Estimated)
June 30, 2026
Last Updated
February 17, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share